These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14671400)

  • 1. Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children.
    Hagenäs L; Hertel T
    Horm Res; 2003; 60 Suppl 3():65-70. PubMed ID: 14671400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress report: growth hormone in skeletal dysplasia.
    Bridges NA; Brook CG
    Horm Res; 1994; 42(4-5):231-4. PubMed ID: 7868078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT; Eklöf O; Ivarsson S; Aronson S; Westphal O; Sipilä I; Kaitila I; Bland J; Veimo D; Müller J; Mohnike K; Neumeyer L; Ritzen M; Hagenäs L
    Acta Paediatr; 2005 Oct; 94(10):1402-10. PubMed ID: 16299871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton).
    Kanaka-Gantenbein C
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):17-26. PubMed ID: 11220700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal dysplasias: response to growth hormone therapy.
    Burren CP; Werther GA
    J Pediatr Endocrinol Metab; 1996; 9(1):31-40. PubMed ID: 8887131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.
    Noordam C; Peer PG; Francois I; De Schepper J; van den Burgt I; Otten BJ
    Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of growth hormone therapy for patients with skeletal dysplasia.
    Kanazawa H; Tanaka H; Inoue M; Yamanaka Y; Namba N; Seino Y
    J Bone Miner Metab; 2003; 21(5):307-10. PubMed ID: 12928832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.
    Kubota T; Wang W; Miura K; Nakayama H; Yamamoto K; Fujiwara M; Ohata Y; Tachibana M; Kitaoka T; Takakuwa S; Miyoshi Y; Namba N; Ozono K
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):845-50. PubMed ID: 26814021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype.
    Tanaka H; Kubo T; Yamate T; Ono T; Kanzaki S; Seino Y
    Eur J Endocrinol; 1998 Mar; 138(3):275-80. PubMed ID: 9539301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.
    Noonan JA; Kappelgaard AM
    Horm Res Paediatr; 2015; 83(3):157-66. PubMed ID: 25503994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Growth Hormone Treatment in Skeletal Dysplasia - A Review.
    Kochar IS; Chugh R
    Pediatr Endocrinol Rev; 2020 Aug; 17(4):327-330. PubMed ID: 32780956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P; Bjerknes R; Dahlgren J; Dunkel L; Gustafsson J; Juul A; Kriström B; Tapanainen P; Aberg V
    Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia.
    Shohat M; Tick D; Barakat S; Bu X; Melmed S; Rimoin DL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4033-7. PubMed ID: 8923856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
    Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
    Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.